Enhabit, Inc. (NYSE:EHAB) Receives $12.08 Consensus Price Target from Analysts

Shares of Enhabit, Inc. (NYSE:EHAB) have received an average recommendation of “Reduce” from the seven ratings firms that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $12.08.

EHAB has been the topic of a number of analyst reports. Jefferies Financial Group dropped their price objective on shares of Enhabit from $15.00 to $14.00 and set a “buy” rating on the stock in a research note on Wednesday, March 6th. UBS Group upgraded shares of Enhabit from a “sell” rating to a “neutral” rating and set a $9.50 price objective on the stock in a research note on Thursday, March 7th. Finally, Oppenheimer reiterated a “market perform” rating on shares of Enhabit in a research note on Thursday, March 7th.

Institutional Investors Weigh In On Enhabit

Several hedge funds and other institutional investors have recently bought and sold shares of EHAB. Deerfield Management Company L.P. Series C increased its stake in Enhabit by 3.9% in the 3rd quarter. Deerfield Management Company L.P. Series C now owns 4,997,746 shares of the company’s stock worth $56,225,000 after purchasing an additional 187,943 shares in the last quarter. Scopia Capital Management LP increased its stake in Enhabit by 9.3% in the 3rd quarter. Scopia Capital Management LP now owns 2,091,315 shares of the company’s stock worth $23,527,000 after purchasing an additional 177,400 shares in the last quarter. JANA Partners Management LP purchased a new position in Enhabit in the 3rd quarter worth about $20,532,000. Ancora Advisors LLC increased its stake in Enhabit by 414.5% in the 3rd quarter. Ancora Advisors LLC now owns 1,705,788 shares of the company’s stock worth $19,190,000 after purchasing an additional 1,374,231 shares in the last quarter. Finally, Schroder Investment Management Group increased its stake in Enhabit by 0.8% in the 3rd quarter. Schroder Investment Management Group now owns 1,685,885 shares of the company’s stock worth $18,966,000 after purchasing an additional 13,387 shares in the last quarter.

Enhabit Trading Down 0.9 %

NYSE EHAB opened at $10.18 on Thursday. Enhabit has a one year low of $7.12 and a one year high of $14.59. The company’s 50 day moving average price is $10.25 and its 200 day moving average price is $9.89. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.53 and a current ratio of 1.53. The firm has a market capitalization of $510.63 million, a price-to-earnings ratio of -6.28, a PEG ratio of 1.57 and a beta of 1.96.

Enhabit (NYSE:EHAB) last posted its quarterly earnings results on Wednesday, March 6th. The company reported $0.03 EPS for the quarter, beating the consensus estimate of $0.02 by $0.01. The firm had revenue of $260.60 million for the quarter, compared to analyst estimates of $260.30 million. Enhabit had a negative net margin of 7.69% and a positive return on equity of 1.55%. During the same quarter last year, the firm posted $0.32 earnings per share. On average, sell-side analysts predict that Enhabit will post 0.24 EPS for the current year.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.